201 related articles for article (PubMed ID: 22233302)
1. A cross-sectional observational study to investigate daily symptom variability, effects of symptom on morning activities and therapeutic expectations of patients and physicians in COPD-SUNRISE study.
Kuyucu T; Güçlü SZ; Saylan B; Demir C; Senol T; Güner S; Koyuncu E; Ozen F; Oztürk S; Cangül Z; Ağanoğlu S; Ozkaya S; Ocak SC; Akkurt H; Intepe YS; Bayrak MG; Güler T; Bekçi TT; Soyyiğit S; Seyfettin S; Kula O; Akbay MO; Büyükgöze B; Asal G; Başlilar S; Oztürk O;
Tuberk Toraks; 2011; 59(4):328-39. PubMed ID: 22233302
[TBL] [Abstract][Full Text] [Related]
2. A cross sectional observational study on the influence of chronic obstructive pulmonary disease on activities of daily living: the COPD-Life study.
Polatlı M; Bilgin C; Şaylan B; Başlılar Ş; Toprak E; Ergen H; Bakan ND; Kart L; Kılıç Z; Üstünel A; Şengün A; Varol Y; Yılmaz A; Ataol Ç; Bulgur D; Bozdoğan S; Tunaboyu İ; Özkan ZG; Uysal E; Gülgösteren S; Akın N; Selim Y; Irmak M; Turgut E; Keskin O; Bektaş Uysal H; Sofuoğlu N; Yılmaz M;
Tuberk Toraks; 2012; 60(1):1-12. PubMed ID: 22554361
[TBL] [Abstract][Full Text] [Related]
3. Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD.
Keam SJ; Keating GM
Treat Respir Med; 2004; 3(4):247-68. PubMed ID: 15350163
[TBL] [Abstract][Full Text] [Related]
4. The association between objectively measured physical activity and morning symptoms in COPD.
van Buul AR; Kasteleyn MJ; Chavannes NH; Taube C
Int J Chron Obstruct Pulmon Dis; 2017; 12():2831-2840. PubMed ID: 29042764
[TBL] [Abstract][Full Text] [Related]
5. Symptom variability in patients with severe COPD: a pan-European cross-sectional study.
Kessler R; Partridge MR; Miravitlles M; Cazzola M; Vogelmeier C; Leynaud D; Ostinelli J
Eur Respir J; 2011 Feb; 37(2):264-72. PubMed ID: 21115606
[TBL] [Abstract][Full Text] [Related]
6. A Cross-Sectional Study in Patients with Severe COPD to Assess the Perception of Symptom Variability (COPVAR) in the Middle East and Africa.
Kokturk N; Abuharbid W; Albanna AS; Gunen H; Gurgun A; Khadadah M; Malvolti E; Soliman M; van Zyl-Smit R; Zidouni N; Alzaabi A
Int J Chron Obstruct Pulmon Dis; 2019; 14():2959-2970. PubMed ID: 31908444
[TBL] [Abstract][Full Text] [Related]
7. A cross-sectional assessment of the burden of COPD symptoms in the US and Europe using the National Health and Wellness Survey.
Ding B; DiBonaventura M; Karlsson N; Bergström G; Holmgren U
Int J Chron Obstruct Pulmon Dis; 2017; 12():529-539. PubMed ID: 28223793
[TBL] [Abstract][Full Text] [Related]
8. Impact and factors associated with nighttime and early morning symptoms among patients with chronic obstructive pulmonary disease.
Stephenson JJ; Cai Q; Mocarski M; Tan H; Doshi JA; Sullivan SD
Int J Chron Obstruct Pulmon Dis; 2015; 10():577-86. PubMed ID: 25844033
[TBL] [Abstract][Full Text] [Related]
9. Exacerbations of chronic obstructive pulmonary disease.
Wedzicha JA; Donaldson GC
Respir Care; 2003 Dec; 48(12):1204-13; discussion 1213-5. PubMed ID: 14651761
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and impact of respiratory symptoms in a population of patients with COPD in Latin America: The LASSYC observational study.
Miravitlles M; Menezes A; López Varela MV; Casas A; Ugalde L; Ramirez-Venegas A; Mendoza L; López A; Wehrmeister FC; Surmont F; Montes de Oca M
Respir Med; 2018 Jan; 134():62-69. PubMed ID: 29413510
[TBL] [Abstract][Full Text] [Related]
11. Morning and night symptoms in primary care COPD patients: a cross-sectional and longitudinal study. An UNLOCK study from the IPCRG.
Tsiligianni I; Metting E; van der Molen T; Chavannes N; Kocks J
NPJ Prim Care Respir Med; 2016 Jul; 26():16040. PubMed ID: 27442618
[TBL] [Abstract][Full Text] [Related]
12. Effect of CArbocisteine in Prevention of exaceRbation of chronic obstructive pulmonary disease (CAPRI study): An observational study.
Esposito A; Valentino MR; Bruzzese D; Bocchino M; Ponticiello A; Stanziola A; Sanduzzi A
Pulm Pharmacol Ther; 2016 Apr; 37():85-8. PubMed ID: 26970503
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of twice-daily glycopyrrolate in patients with stable, symptomatic COPD with moderate-to-severe airflow limitation: the GEM1 study.
LaForce C; Feldman G; Spangenthal S; Eckert JH; Henley M; Patalano F; D'Andrea P
Int J Chron Obstruct Pulmon Dis; 2016; 11():1233-43. PubMed ID: 27354782
[TBL] [Abstract][Full Text] [Related]
14. Evaluating the impact of morning symptoms in COPD using the Capacity of Daily Living during the Morning (CDLM) questionnaire.
Núñez A; Esquinas C; Barrecheguren M; Calle M; Casamor R; Miravitlles M
Int J Chron Obstruct Pulmon Dis; 2018; 13():3837-3844. PubMed ID: 30538445
[TBL] [Abstract][Full Text] [Related]
15. Symptom variability and control in COPD: Advantages of dual bronchodilation therapy.
Di Marco F; Santus P; Scichilone N; Solidoro P; Contoli M; Braido F; Corsico AG
Respir Med; 2017 Apr; 125():49-56. PubMed ID: 28340862
[TBL] [Abstract][Full Text] [Related]
16. Symptoms and impact of COPD assessed by an electronic diary in patients with moderate-to-severe COPD: psychometric results from the SHINE study.
Kulich K; Keininger DL; Tiplady B; Banerji D
Int J Chron Obstruct Pulmon Dis; 2015; 10():79-94. PubMed ID: 25609942
[TBL] [Abstract][Full Text] [Related]
17. The variability of respiratory symptoms and associated factors in COPD.
Miravitlles M; Izquierdo JL; Esquinas C; Pérez M; Calle M; López-Campos JL; Rodríguez González-Moro JM; Casanova C; Esteban C; de Lucas P
Respir Med; 2017 Aug; 129():165-172. PubMed ID: 28732827
[TBL] [Abstract][Full Text] [Related]
18. Common lung conditions: chronic obstructive pulmonary disease.
Delzell JE
FP Essent; 2013 Jun; 409():23-31. PubMed ID: 23767419
[TBL] [Abstract][Full Text] [Related]
19. [Long-term treatment strategy in chronic obstructive pulmonary disease: how to change the course of the disease].
Devillier P; Salvator H; Roche N; Grassin-Delyle S; Naline E; Dorocant S; Neveu H
Presse Med; 2014 Dec; 43(12 Pt 1):1368-80. PubMed ID: 25455634
[TBL] [Abstract][Full Text] [Related]
20. Improvements in patient-reported outcomes: A prospective, non-interventional study with aclidinium bromide for treatment of COPD.
Marth K; Schuller E; Pohl W
Respir Med; 2015 May; 109(5):616-24. PubMed ID: 25796962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
